InspireMD, Inc. — Director's Dealing 2020

Sep 2, 2020

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: InspireMD, Inc. (NSPR)
CIK: 0001433607
Period of Report: 2020-08-31

Reporting Person: Slosman Marvin (Director, CEO and President)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2020-08-31	Common Stock	A	1175287	—	Acquired	1413218	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2020-08-31	Options (right to buy)	$0.39	A	391762	Acquired	2030-08-31	Common stock (391762)	Direct

Holdings (Derivative)

Security	Exercise Price	Expiration	Underlying	Shares	Ownership
Warrants	$0.495	2025-06-02	Common stock (55550)	55550	Direct

Footnotes

F1: These shares of common stock represent restricted stock units ("RSUs"), which each vest and become exercisable in three equal annual installments, with 1/3 vesting on each of August 31, 2021, August 31, 2022 and August 31, 2023, subject to the Reporting Person's continued service.

F2: Consists of (i) an aggregate of 1,357,668 shares of common stock represented by RSUs, which vest over time, subject to the Reporting Person's continued service, and (ii) 55,550 shares of common stock.

F3: The Reporting Person has not engaged in any reportable transactions with respect to these derivative securities of the Issuer and is including his ownership of these securities for informational purposes only in this Form 4.

F4: The options vest and become exercisable in three equal installments, with 1/3 vesting on each of August 31, 2021, August 31, 2022 and August 31, 2023, subject to the Reporting Person's continued service.